China Health Industries Holdings, Inc. (CHHE)

Market Cap	6.55K +9,830.3%
Revenue (ttm)	95.95K +77.5%
Net Income	-1.36M
EPS	-0.02
Shares Out	65.54M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0001
Beta	-18.99
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CHHE

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft caps...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 34
• Stock Exchange: OTCMKTS
• Ticker Symbol: CHHE

Financial Performance

In fiscal year 2023, CHHE's revenue was $111,579, an increase of 41689.89% compared to the previous year's $267. Losses were -$408,772, 15.5% more than in 2022.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 26, 2026

Data Sources Report a data error